<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4421">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04734912</url>
  </required_header>
  <id_info>
    <org_study_id>ETNE v1.0</org_study_id>
    <nct_id>NCT04734912</nct_id>
  </id_info>
  <brief_title>Evaluation of Transnasal Endoscopy During COVID-19 Pandemic</brief_title>
  <official_title>Evaluation of Transnasal Endoscopy During COVID-19 Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who received the indication for endoscopic diagnostics using gastroscopy in&#xD;
      transnasal technique will be included into the study. The examination is carried out in&#xD;
      standard technique and is not influenced by the study. Following the examination, patient&#xD;
      data is collected pseudonymously and a questionnaire is submitted to the patient.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COVID-19 is transmitted, among other things, by a droplet infection. Conventional gastroscopy&#xD;
      through the patient's mouth is therefore considered a high-risk examination for the medical&#xD;
      and nursing staff. Alternatively, gastroscopy can also be performed through the patient's&#xD;
      nose. An advantage here is that the aerosol formation is naturally significantly reduced and&#xD;
      the patient usually does not need sedation, since in transnasal endoscopy no stranglehold&#xD;
      occurs. Transnasal endoscopy therefore appears to us, especially during the COVID-19&#xD;
      pandemic, as a safe alternative to conventional gastroscopy.&#xD;
&#xD;
      Patients who received the indication for endoscopic diagnostics using gastroscopy in&#xD;
      transnasal technique will be included into the study. The examination is carried out in&#xD;
      standard technique and is not influenced by the study. Following the examination, patient&#xD;
      data is collected pseudonymously and a questionnaire is sumbitted to the patient.&#xD;
&#xD;
      Only patients who have the indication for gastroscopy in transnasal technique are included. A&#xD;
      specific risk to patients cannot be foreseen.This study does not interfere with diagnostics&#xD;
      or therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>all patients with indication f√ºr gastroscopy in transnasal techique are included.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaire</measure>
    <time_frame>after examination, about 15 minutes</time_frame>
    <description>a questionnaire with 5 questions regarding the quality of the examination, technique and safety is presented to the patients</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Endoscopy</condition>
  <arm_group>
    <arm_group_label>Gastroscopy in transnasal technique</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients with indication for gastroscopy in transnasal techqiue are included.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>gastroscopy in transnasal techique</intervention_name>
    <description>All patients with indication for gastroscopy in transnasal technique are included.</description>
    <arm_group_label>Gastroscopy in transnasal technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indication for transnasal endoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breast feeding&#xD;
&#xD;
          -  contraindication to transnasal endoscopy&#xD;
&#xD;
          -  pronounced blood clotting disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmut Neumann, M.D. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Mainz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helmut Neumann, M.D. PhD</last_name>
    <phone>+49 (0) 6131</phone>
    <phone_ext>176838</phone_ext>
    <email>helmut.neumann@unimedizin-mainz.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tanja Bender, M.A.</last_name>
    <phone>+49 (0) 6131</phone>
    <phone_ext>176838</phone_ext>
    <email>tanja.bender@unimedizin-mainz.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rhenanie-Palatinate</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prof. Helmut Neumann, M.D. PhD</last_name>
      <phone>+49 (0) 6131</phone>
      <phone_ext>176838</phone_ext>
      <email>helmut.neumann@unimedizin-mainz.de</email>
    </contact>
    <contact_backup>
      <last_name>Tanja Bender, M.A:</last_name>
      <phone>+49 (0) 6131</phone>
      <phone_ext>176838</phone_ext>
      <email>tanja.bender@unimedizin-mainz.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 13, 2021</study_first_submitted>
  <study_first_submitted_qc>January 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 2, 2021</study_first_posted>
  <last_update_submitted>January 30, 2021</last_update_submitted>
  <last_update_submitted_qc>January 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Prof. Helmut Neumann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>gastroscopy</keyword>
  <keyword>transnasal</keyword>
  <keyword>nursing</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>A publication of the results is planned.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

